Pages that link to "Q36356138"

The following pages link to Role of N-linked glycans in the interaction between the envelope glycoprotein of human immunodeficiency virus and its CD4 cellular receptor. Structural enzymatic analysis (Q36356138):

Displaying 50 items.

• Glycosylation is necessary for the correct folding of human immunodeficiency virus gp120 in CD4 binding (Q24644617) ‎ (← links)
• Functional role of the glycan cluster of the human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) ectodomain (Q24645233) ‎ (← links)
• Carbohydrate binding properties of the envelope glycoproteins of human immunodeficiency virus type 1 (Q28185691) ‎ (← links)
• Effect of various glycosidase treatments on the resistance of the HIV-1 envelope to degradation (Q28235367) ‎ (← links)
• Inhibition of HIV and SIV infectivity by blockade of α-glucosidase activity (Q28268842) ‎ (← links)
• Role of asparagine-linked glycosylation in human immunodeficiency virus type 1 transmembrane envelope function (Q28293345) ‎ (← links)
• Inhibition of Human Immunodeficiency Virus Infectivity by Chloroquine (Q28323345) ‎ (← links)
• Human alpha1-acid glycoprotein binds to CCR5 expressed on the plasma membrane of human primary macrophages (Q28364255) ‎ (← links)
• Inhibition of alpha-glucosidase I of the glycoprotein-processing enzymes by 6-O-butanoyl castanospermine (MDL 28,574) and its consequences in human immunodeficiency virus-infected T cells (Q28369132) ‎ (← links)
• Functional contributions of carbohydrate on AIDS virus glycoprotein (Q30397572) ‎ (← links)
• Resistance of native, oligomeric envelope on simian immunodeficiency virus to digestion by glycosidases (Q33827027) ‎ (← links)
• Influence of carbohydrate moieties on the immunogenicity of human immunodeficiency virus type 1 recombinant gp160 (Q33933098) ‎ (← links)
• An aptamer that neutralizes R5 strains of human immunodeficiency virus type 1 blocks gp120-CCR5 interaction (Q34092668) ‎ (← links)
• Fundamental difference in the content of high-mannose carbohydrate in the HIV-1 and HIV-2 lineages (Q34120130) ‎ (← links)
• Partial enzymatic deglycosylation preserves the structure of cleaved recombinant HIV-1 envelope glycoprotein trimers (Q34285680) ‎ (← links)
• alpha 1-Acid glycoprotein binds human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein via N-linked glycans (Q34314212) ‎ (← links)
• Purification and characterization of oligomeric envelope glycoprotein from a primary R5 subtype B human immunodeficiency virus (Q34332284) ‎ (← links)
• Lectin—Carbohydrate Interactions and Infectivity of Human Immunodeficiency Virus Type 1 (HIV-1) (Q34609824) ‎ (← links)
• Short chain fatty acids potently induce latent HIV-1 in T-cells by activating P-TEFb and multiple histone modifications (Q34656952) ‎ (← links)
• The blood group antigen-related glycoepitopes: Key structural determinants in immunogenesis and AIDS pathogenesis (Q35160742) ‎ (← links)
• The presence of host-derived HLA-DR1 on human immunodeficiency virus type 1 increases viral infectivity (Q35877952) ‎ (← links)
• The auto-regulation model: a unified concept of how HIV regulates its infectivity, pathogenesis and persistence (Q36055538) ‎ (← links)
• Different extracellular domains of the neural cell adhesion molecule (N-CAM) are involved in different functions (Q36531563) ‎ (← links)
• Characterization of human immunodeficiency virus type 1 gp120 binding to liposomes containing galactosylceramide (Q36635210) ‎ (← links)
• Specificity of antibodies produced against native or desialylated human immunodeficiency virus type 1 recombinant gp160 (Q36644697) ‎ (← links)
• The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection. (Q36669879) ‎ (← links)
• Binding of the coronavirus mouse hepatitis virus A59 to its receptor expressed from a recombinant vaccinia virus depends on posttranslational processing of the receptor glycoprotein (Q36698686) ‎ (← links)
• Inhibition of gp160 and CD4 maturation in U937 cells after both defective and productive infections by human immunodeficiency virus type 1. (Q36827782) ‎ (← links)
• Glycosylation of gp41 of simian immunodeficiency virus shields epitopes that can be targets for neutralizing antibodies (Q36994698) ‎ (← links)
• Immunological features of human immunodeficiency virus disease (Q37851260) ‎ (← links)
• Molecular analysis of receptor binding and infectivity of the human immunodeficiency virus (Q38307207) ‎ (← links)
• Antiviral activity of derivatized dextrans on HIV-1 infection of primary macrophages and blood lymphocytes (Q39443158) ‎ (← links)
• Comparative evaluation of trimeric envelope glycoproteins derived from subtype C and B HIV-1 R5 isolates (Q39484948) ‎ (← links)
• Purification, Characterization, and Immunogenicity of a Soluble Trimeric Envelope Protein Containing a Partial Deletion of the V2 Loop Derived from SF162, an R5-Tropic Human Immunodeficiency Virus Type 1 Isolate (Q39484956) ‎ (← links)
• Role of N-linked glycans of envelope glycoproteins in infectivity of human immunodeficiency virus type 1. (Q40109264) ‎ (← links)
• Human immunodeficiency virus type 1-associated CD4 downmodulation. (Q40567149) ‎ (← links)
• The role of CD4 and its downmodulation in establishment and maintenance of HIV-1 infection. (Q40569844) ‎ (← links)
• Effect of alpha-1 antitrypsin Portland variant (alpha 1-PDX) on HIV-1 replication (Q40844705) ‎ (← links)
• Specificity of anti-peptide antibodies elicited against synthetic peptides mimicking conserved regions of HIV1 envelope glycoprotein (Q41658062) ‎ (← links)
• N-Acetyl-β-d-glucosaminyl-binding properties of the envelope glycoprotein of human immunodeficiency virus type1 (Q41678831) ‎ (← links)
• Regulated expression allows high level production and secretion of HIV-1 gp120 envelope glycoprotein in Drosophila Schneider cells (Q41698821) ‎ (← links)
• Fusion intermediates of HIV-1 gp41 as targets for antibody production: design, synthesis, and HR1-HR2 complex purification and characterization of generated antibodies. (Q43488425) ‎ (← links)
• Multiple glycosylated forms of the respiratory syncytial virus fusion protein are expressed in virus-infected cells (Q43830376) ‎ (← links)
• Glycosylation and stability of mature HIV envelope glycoprotein conformation under various conditions (Q44033902) ‎ (← links)
• The interaction of a glycosaminoglycan heparin, with HIV-1 major envelope glycoprotein (Q44245897) ‎ (← links)
• Effect of sialic acid removal on the antibody response to the third variable domain of human immunodeficiency virus type-1 envelope glycoprotein (Q44306164) ‎ (← links)
• Expression, purification, and characterization of recombinant HIV gp140. The gp41 ectodomain of HIV or simian immunodeficiency virus is sufficient to maintain the retroviral envelope glycoprotein as a trimer (Q45736020) ‎ (← links)
• Attachment of human immunodeficiency virus-1 (HIV-1) particles bearing host-encoded B7-2 proteins leads to nuclear factor-kappa B- and nuclear factor of activated T cells-dependent activation of HIV-1 long terminal repeat transcription (Q45739553) ‎ (← links)
• Specificity of antipeptide antibodies produced against V2 and V3 regions of the external envelope of human immunodeficiency virus type 2. (Q45778924) ‎ (← links)
• The role of calcium and N-linked glycans in the oligomerization and carbohydrate binding properties of human immunodeficiency virus external envelope glycoprotein (Q45784857) ‎ (← links)